Francis I Perier Jr
CIK 1304404 · Chief Financial Officer · last filed 2025-07-02
Francis I Perier Jr is a Chief Financial Officer who has filed 37 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for SWTX, was dated Jul 2, 2025. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. 31 SEC filings were submitted jointly with FOREST LABORATORIES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
909 THIRD AVENUE
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Financial Officer | 0 | $46.99 | $0 | $0 | 11 | 2025-07-02 |
| Forest Laboratories, LLC (FRX) Delisted | EVP - Chief Financial Officer | 90,630 | $12.00 | $1.09M | -$1.38M | 25 | 2013-12-10 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −60,889 | $0 | EDGAR |
| 2025-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +11,779 | $0 | EDGAR |
| 2025-01-07 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −10,143 | -$389.6K | EDGAR |
| 2024-01-08 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +15,790 | -$215.2K | EDGAR |
| 2023-01-10 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −1,090 | -$28.8K | EDGAR |
| 2023-01-09 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +17,051 | -$65.3K | EDGAR |
| 2022-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −1,307 | -$73.3K | EDGAR |
| 2022-01-11 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −1,846 | -$103.5K | EDGAR |
| 2022-01-10 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +18,809 | $0 | EDGAR |
| 2021-01-11 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.